SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Cell MedX Corp. – ‘10-Q’ for 11/30/19 – ‘ZIP’

On:  Tuesday, 1/14/20, at 3:14pm ET   ·   For:  11/30/19   ·   Accession #:  1393905-20-9   ·   File #:  0-54500

Previous ‘10-Q’:  ‘10-Q’ on 10/15/19 for 8/31/19   ·   Next:  ‘10-Q’ on 4/14/20 for 2/29/20   ·   Latest:  ‘10-Q’ on 4/15/24 for 2/29/24   ·   19 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/14/20  Cell MedX Corp.                   10-Q       11/30/19   65:2.2M                                   Empire Stock Transf… Inc

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    331K 
 2: EX-10.53    Loan Agreement and Note Payable Dated September 4,  HTML     26K 
                2019                                                             
 3: EX-10.54    Loan Agreement and Note Payable Dated September 6,  HTML     26K 
                2019                                                             
 4: EX-10.55    Loan Agreement and Note Payable Dated September     HTML     26K 
                16, 2019                                                         
 5: EX-10.56    Loan Agreement and Note Payable Dated September     HTML     26K 
                19, 2019                                                         
 6: EX-10.57    Loan Agreement and Note Payable Dated September     HTML     26K 
                20, 2019                                                         
 7: EX-10.58    Loan Agreement and Note Payable Dated October 30,   HTML     26K 
                2019                                                             
 8: EX-10.59    Loan Agreement and Note Payable Dated October 30,   HTML     26K 
                2019, With Rain Communications Corp.                             
 9: EX-31.1     Certification -- §302 - SOA'02                      HTML     23K 
10: EX-31.2     Certification -- §302 - SOA'02                      HTML     23K 
11: EX-32.1     Certification -- §906 - SOA'02                      HTML     19K 
12: EX-32.2     Certification -- §906 - SOA'02                      HTML     19K 
58: R1          Document and Entity Information                     HTML     68K 
37: R2          Consolidated Balance Sheets                         HTML     79K 
24: R3          Consolidated Balance Sheets - Parenthetical         HTML     27K 
46: R4          Consolidated Statements of Operations               HTML     72K 
57: R5          Consolidated Statement of Stockholders' Deficit     HTML     57K 
36: R6          Consolidated Statements of Cash Flows               HTML     85K 
23: R7          Organization and Nature of Operations               HTML     28K 
47: R8          Related Party Transactions Disclosure               HTML     39K 
53: R9          Inventory Disclosure                                HTML     24K 
21: R10         Other Current Assets Disclosure                     HTML     22K 
39: R11         Equipment Disclosure                                HTML     29K 
54: R12         Unearned Revenue Disclosure                         HTML     32K 
48: R13         Revenue Disclosure                                  HTML     26K 
22: R14         Notes and Advances Payable Disclosure               HTML     49K 
40: R15         Share Capital Disclosure                            HTML     53K 
55: R16         Subsequent Event Disclosure                         HTML     22K 
49: R17         Organization and Nature of Operations: Going        HTML     24K 
                Concern (Policies)                                               
25: R18         Related Party Transactions Disclosure: Schedule of  HTML     31K 
                Amounts Due to Related Parties (Tables)                          
38: R19         Related Party Transactions Disclosure: Schedule of  HTML     28K 
                Transactions with Related Parties (Tables)                       
64: R20         Equipment Disclosure: Amortization schedule for     HTML     29K 
                the equipment (Tables)                                           
43: R21         Unearned Revenue Disclosure: Changes to Unearned    HTML     30K 
                Revenue (Tables)                                                 
27: R22         Revenue Disclosure: Schedule of Revenue and         HTML     25K 
                Associated Costs (Tables)                                        
32: R23         Notes and Advances Payable Disclosure: Schedule of  HTML     41K 
                Short-term Loans and Advances Outstanding (Tables)               
65: R24         Share Capital Disclosure: Schedule of Stock Option  HTML     31K 
                Activity (Tables)                                                
44: R25         Share Capital Disclosure: Schedule of Stock         HTML     27K 
                Options Outstanding (Tables)                                     
28: R26         Share Capital Disclosure: Schedule of Warrant       HTML     26K 
                Activity (Tables)                                                
33: R27         Share Capital Disclosure: Schedule of Warrant       HTML     31K 
                Details (Tables)                                                 
63: R28         Organization and Nature of Operations: Going        HTML     23K 
                Concern (Details)                                                
45: R29         Related Party Transactions Disclosure: Schedule of  HTML     33K 
                Amounts Due to Related Parties (Details)                         
52: R30         Related Party Transactions Disclosure: Schedule of  HTML     28K 
                Transactions with Related Parties (Details)                      
60: R31         Inventory Disclosure (Details)                      HTML     36K 
35: R32         Other Current Assets Disclosure (Details)           HTML     25K 
20: R33         Equipment Disclosure: Amortization schedule for     HTML     30K 
                the equipment (Details)                                          
51: R34         Unearned Revenue Disclosure: Changes to Unearned    HTML     31K 
                Revenue (Details)                                                
59: R35         Unearned Revenue Disclosure (Details)               HTML     24K 
34: R36         Revenue Disclosure: Schedule of Revenue and         HTML     32K 
                Associated Costs (Details)                                       
19: R37         Notes and Advances Payable Disclosure: Schedule of  HTML     41K 
                Short-term Loans and Advances Outstanding                        
                (Details)                                                        
50: R38         Notes and Advances Payable Disclosure (Details)     HTML     37K 
61: R39         Share Capital Disclosure (Details)                  HTML     39K 
42: R40         Share Capital Disclosure: Schedule of Stock Option  HTML     28K 
                Activity (Details)                                               
62: R41         Share Capital Disclosure: Schedule of Stock         HTML     30K 
                Options Outstanding (Details)                                    
31: R42         Share Capital Disclosure: Schedule of Warrant       HTML     27K 
                Activity (Details)                                               
26: R43         Share Capital Disclosure: Schedule of Warrant       HTML     32K 
                Details (Details)                                                
41: R44         Subsequent Event Disclosure (Details)               HTML     22K 
56: XML         IDEA XML File -- Filing Summary                      XML    104K 
30: EXCEL       IDEA Workbook of Financial Reports                  XLSX     43K 
13: EX-101.INS  XBRL Instance -- cmxc-20191130                       XML    571K 
15: EX-101.CAL  XBRL Calculations -- cmxc-20191130_cal               XML     63K 
16: EX-101.DEF  XBRL Definitions -- cmxc-20191130_def                XML    251K 
17: EX-101.LAB  XBRL Labels -- cmxc-20191130_lab                     XML    436K 
18: EX-101.PRE  XBRL Presentations -- cmxc-20191130_pre              XML    395K 
14: EX-101.SCH  XBRL Schema -- cmxc-20191130                         XSD    108K 
29: ZIP         XBRL Zipped Folder -- 0001393905-20-000009-xbrl      Zip     53K 


‘ZIP’   —   XBRL Zipped Folder — 0001393905-20-000009-xbrl


This is an XBRL Zipped Folder.

        Download this zipped .zip folder
 
Files:cmxc-20191130.xml
cmxc-20191130.xsd
cmxc-20191130_cal.xml
cmxc-20191130_def.xml
cmxc-20191130_lab.xml
cmxc-20191130_pre.xml


19 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/16/24  Cell MedX Corp.                   10-Q       11/30/23   46:2.3M                                   Empire Stock Transf… Inc
10/16/23  Cell MedX Corp.                   10-Q        8/31/23   42:1.9M                                   Empire Stock Transf… Inc
 9/01/23  Cell MedX Corp.                   10-K        5/31/23   73:3.2M                                   Empire Stock Transf… Inc
 6/29/23  Cell MedX Corp.                   10-Q        2/28/23   53:2.5M                                   Empire Stock Transf… Inc
 5/19/23  Cell MedX Corp.                   10-Q       11/30/22   53:2.4M                                   Empire Stock Transf… Inc
 4/19/23  Cell MedX Corp.                   10-Q        8/31/22   51:2.2M                                   Empire Stock Transf… Inc
 4/07/23  Cell MedX Corp.                   10-K        5/31/22   90:3.6M                                   Empire Stock Transf… Inc
 4/11/22  Cell MedX Corp.                   10-Q        2/28/22   56:2.5M                                   Empire Stock Transf… Inc
 1/12/22  Cell MedX Corp.                   10-Q       11/30/21   54:2.4M                                   Empire Stock Transf… Inc
10/14/21  Cell MedX Corp.                   424B3                  1:365K                                   Empire Stock Transf… Inc
10/14/21  Cell MedX Corp.                   10-Q        8/31/21   50:2.2M                                   Empire Stock Transf… Inc
10/12/21  Cell MedX Corp.                   424B3                  1:705K                                   Empire Stock Transf… Inc
 8/30/21  Cell MedX Corp.                   10-K        5/31/21   83:3.7M                                   Empire Stock Transf… Inc
 4/09/21  Cell MedX Corp.                   424B3                  1:501K                                   Empire Stock Transf… Inc
 4/09/21  Cell MedX Corp.                   10-Q        2/28/21   56:2.8M                                   Empire Stock Transf… Inc
 3/04/21  Cell MedX Corp.                   S-1                   78:3.8M                                   Empire Stock Transf… Inc
 1/14/21  Cell MedX Corp.                   10-Q       11/30/20   53:2M                                     Empire Stock Transf… Inc
10/15/20  Cell MedX Corp.                   10-Q        8/31/20   51:1.9M                                   Empire Stock Transf… Inc
 9/15/20  Cell MedX Corp.                   10-K        5/31/20   84:2.9M                                   Empire Stock Transf… Inc
Top
Filing Submission 0001393905-20-000009   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., May 9, 9:26:10.2pm ET